Literature DB >> 24115570

Rubinstein-Taybi syndrome predisposing to non-WNT, non-SHH, group 3 medulloblastoma.

Franck Bourdeaut1, Catherine Miquel, Wilfrid Richer, Jacques Grill, Michel Zerah, Camille Grison, Gaelle Pierron, Jeanne Amiel, Clementine Krucker, Francois Radvanyi, Laurence Brugieres, Olivier Delattre.   

Abstract

Medulloblastomas (MB) are classified in four subgroups: the well defined WNT and Sonic Hedgehog (SHH) subgroups, and the less defined groups 3 and 4. They occasionally occur in the context of a cancer predisposition syndrome. While germline APC mutations predispose to WNT MB, germline mutations in SUFU, PTCH1, and TP53 predispose to SHH tumors. We report on a child with a Rubinstein-Taybi syndrome (RTS) due to a germline deletion in CREBBP, who developed a MB. Biological profilings demonstrate that this tumor belongs to the group 3. RTS may therefore be the first predisposition syndrome identified for non-WNT/non-SHH MB.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  CREBBP; Rubinstein-Taybi syndrome; medulloblastoma; predisposition

Mesh:

Substances:

Year:  2013        PMID: 24115570     DOI: 10.1002/pbc.24765

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  15 in total

1.  De Novo and Inherited Pathogenic Variants in KDM3B Cause Intellectual Disability, Short Stature, and Facial Dysmorphism.

Authors:  Illja J Diets; Roos van der Donk; Kristina Baltrunaite; Esmé Waanders; Margot R F Reijnders; Alexander J M Dingemans; Rolph Pfundt; Anneke T Vulto-van Silfhout; Laurens Wiel; Christian Gilissen; Julien Thevenon; Laurence Perrin; Alexandra Afenjar; Caroline Nava; Boris Keren; Sarah Bartz; Bethany Peri; Gea Beunders; Nienke Verbeek; Koen van Gassen; Isabelle Thiffault; Maxime Cadieux-Dion; Lina Huerta-Saenz; Matias Wagner; Vassiliki Konstantopoulou; Julia Vodopiutz; Matthias Griese; Annekatrien Boel; Bert Callewaert; Han G Brunner; Tjitske Kleefstra; Nicoline Hoogerbrugge; Bert B A de Vries; Vivian Hwa; Andrew Dauber; Jayne Y Hehir-Kwa; Roland P Kuiper; Marjolijn C J Jongmans
Journal:  Am J Hum Genet       Date:  2019-03-28       Impact factor: 11.025

2.  Rubinstein-Taybi Syndrome Associated with Pituitary Macroadenoma: A Case Report.

Authors:  Yasamin Olyaei; J Manuel Sarmiento; Serguei I Bannykh; Doniel Drazin; Robert T Naruse; Wesley King
Journal:  Cureus       Date:  2017-04-11

3.  Group 3 medulloblastoma in a patient with a GYS2 germline mutation and glycogen storage disease 0a.

Authors:  Till Holsten; Konstantinos Tsiakas; Uwe Kordes; Brigitte Bison; Torsten Pietsch; Stefan Rutkowski; René Santer; Ulrich Schüller
Journal:  Childs Nerv Syst       Date:  2017-11-22       Impact factor: 1.475

Review 4.  Epigenetic regulation in medulloblastoma.

Authors:  Jiaqing Yi; Jiang Wu
Journal:  Mol Cell Neurosci       Date:  2017-12-18       Impact factor: 4.314

Review 5.  Germline genetic landscape of pediatric central nervous system tumors.

Authors:  Ivo S Muskens; Chenan Zhang; Adam J de Smith; Jaclyn A Biegel; Kyle M Walsh; Joseph L Wiemels
Journal:  Neuro Oncol       Date:  2019-11-04       Impact factor: 12.300

Review 6.  Ultra-Rare Syndromes: The Example of Rubinstein-Taybi Syndrome.

Authors:  Silvia Spena; Cristina Gervasini; Donatella Milani
Journal:  J Pediatr Genet       Date:  2015-09-28

7.  Medulloblastomas associated with an APC germline pathogenic variant share the good prognosis of CTNNB1-mutated medulloblastomas.

Authors:  Aurore Surun; Pascale Varlet; Laurence Brugières; Brigitte Lacour; Cécile Faure-Conter; Pierre Leblond; Anne-Isabelle Bertozzi-Salomon; Claire Berger; Nicolas André; Eric Sariban; Sandra Raimbault; Fabienne Prieur; Françoise Desseigne; Hélène Zattara; Rosine Guimbaud; Marc Polivka; Marie-Bernadette Delisle; Alexandre Vasiljevic; Claude-Alain Maurage; Dominique Figarella-Branger; Florence Coulet; Léa Guerrini-Rousseau; Claire Alapetite; Christelle Dufour; Chrystelle Colas; François Doz; Franck Bourdeaut
Journal:  Neuro Oncol       Date:  2020-01-11       Impact factor: 12.300

Review 8.  Childhood brain tumor epidemiology: a brain tumor epidemiology consortium review.

Authors:  Kimberly J Johnson; Jennifer Cullen; Jill S Barnholtz-Sloan; Quinn T Ostrom; Chelsea E Langer; Michelle C Turner; Roberta McKean-Cowdin; James L Fisher; Philip J Lupo; Sonia Partap; Judith A Schwartzbaum; Michael E Scheurer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-09-05       Impact factor: 4.254

Review 9.  Rubinstein-Taybi syndrome: clinical features, genetic basis, diagnosis, and management.

Authors:  Donatella Milani; Francesca Maria Paola Manzoni; Lidia Pezzani; Paola Ajmone; Cristina Gervasini; Francesca Menni; Susanna Esposito
Journal:  Ital J Pediatr       Date:  2015-01-20       Impact factor: 2.638

10.  Silencing of Urothelial Carcinoma Associated 1 Inhibits the Proliferation and Migration of Medulloblastoma Cells.

Authors:  Xie Zhengyuan; Xiao Hu; Wang Qiang; Li Nanxiang; Cai Junbin; Zhang Wangming
Journal:  Med Sci Monit       Date:  2017-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.